Skip to content

Clinical trials

Melanoma trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Melanoma Country / region: Taiwan Clear all

46 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20093
20111
20122
20133
20141
20158
20161
20173
20181
20196
20202
20214
20222
20234
20243
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Terminated12
Active, not recruiting8
Recruiting6
Unknown status4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals11
Amgen3
Eli Lilly and Company3
National Taiwan University Hospital3
Daiichi Sankyo2
DualityBio Inc.2
AbbVie1
Astellas Pharma Global Development, Inc.1
Bayer1
BioAtla, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Melanoma46
Carcinoma, Non-Small-Cell Lung25
Squamous Cell Carcinoma of Head and Neck14
Neoplasms12
Carcinoma, Renal Cell10
Colorectal Neoplasms10
Ovarian Neoplasms10
Breast Neoplasms8
Stomach Neoplasms8
Triple Negative Breast Neoplasms8

Trials

Showing 26 to 46 of 46. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.